NCT03947268
Completed
N/A
Palliative Short-course Radiotherapy in Advanced Pelvic Cancer: a Phase II Study (SHARON Project)
ConditionsPalliative Care
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Palliative Care
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Enrollment
- 25
- Primary Endpoint
- Assessment of symptoms [pain]
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The study wants to define the safety and efficacy of a short-course radiation therapy in patients with symptomatic advanced pelvic cancer.
Detailed Description
he study wants to define the safety and efficacy of a short course accelerated radiation therapy delivered in twice daily fractions and 2 consecutive days for symptomatic palliation of advanced solid cancer.
Investigators
Alessio Giuseppe Morganti
Professor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Eligibility Criteria
Inclusion Criteria
- •histologically proven advanced pelvic cancer
- •excluded from curative therapy because of disease stage and/or presence of multiple comorbidities and/or poor performance status
- •age \> 18 years
- •Eastern Cooperative Oncology Group (ECOG) \<3
Exclusion Criteria
- •prior radiotherapy to the same region
Outcomes
Primary Outcomes
Assessment of symptoms [pain]
Time Frame: 1 year]
Pain after treatment is evaluated with the Visual Analogic scale (VAS). Values range from 0 (no pain) to 10 (maximum possible pain).
Secondary Outcomes
- Incidence of Treatment-Emergent Adverse Events [Acute radiation toxicity](1 year)
- Incidence of Treatment-Emergent Adverse Events [Late radiation toxicity](1 year)
- Assessment of the Quality of life (QOL)(1 year)
Similar Trials
Completed
N/A
Palliative Short Course Radiotherapy for Advanced Thoracic CancerPalliative CareNCT03465553IRCCS Azienda Ospedaliero-Universitaria di Bologna53
Completed
N/A
Short Course Radiation Therapy in Palliative TreatmentPalliative CareNCT03196700IRCCS Azienda Ospedaliero-Universitaria di Bologna48
Unknown
N/A
Short Course Radiation Therapy in Palliative Treatment of Complicated Bone MetastasesBone MetastasesRadiotherapyPalliative CareNCT03503682IRCCS Azienda Ospedaliero-Universitaria di Bologna82
Unknown
N/A
Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate CancerHormone-refractory Prostate CancerNCT03658434Zealand University Hospital34
Not Yet Recruiting
Phase 1
Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRCCRCMetastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaNCT06195670Zhejiang Cancer Hospital220